Sign in
8-K/A

Current Report

ArriVent BioPharma, Inc. Filed Acc 0001104659-24-078587

Executive or director change

  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading tm2419108d2_8ka.htm…